Cerebellar Lesions in Multiple System Atrophy: Postmortem MR Imaging−Pathologic Correlations

References

1. 1.↵
   1. Papp MI,
   2. Kahn JE,
   3. Lantos PL,
   4. et al

   . Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79–100

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Dickson DW,
   2. Lin W,
   3. Liu WK,
   4. et al

   . Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 1999;9:721–32

   PubMedWeb of Science
3. 3.↵
   1. Spillantini MG,
   2. Crowther RA,
   3. Jakes R,
   4. et al

   . Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205–08

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Galvin JE,
   2. Lee VMY,
   3. Trojanowski JQ

   . Synucleinopathies: clinical and pathological implications. Arch Neurol 2001;58:186–90

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Wenning GK,
   2. Ben Shlomo Y,
   3. Magalhaes M,
   4. et al

   . Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835–45

   Abstract/FREE Full Text
6. 6.↵
   1. Gilman S,
   2. Low P,
   3. Quinn N,
   4. et al

   . Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res 1998;8:359–62

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Savoiardo M,
   2. Strada L,
   3. Girotti F,
   4. et al

   . Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990;174:693–96

   PubMedWeb of Science
8. 8.↵
   1. Yagishita A

   . MR-pathologic correlations of pontocerebellar lesion in multiple system atrophy. Pathol and Clin Med (Japanese) 1994;12:225–30
9. 9.↵
   1. Schrag A,
   2. Kingsley D,
   3. Phatouros C,
   4. et al

   . Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998;65:65–71

   Abstract/FREE Full Text
10. 10.↵
    1. Yekhlef F,
    2. Ballan G,
    3. Macia F,
    4. et al

    . Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;55:1239–40

    FREE Full Text
11. 11.↵
    1. Bhattacharya K,
    2. Saadia D,
    3. Eisenkraft B,
    4. et al

    . Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol 2002;59:835–42

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Yekhlef F,
    2. Ballan G,
    3. Macia F,
    4. et al

    . Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm 2003;110:151–69

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Le Bihan D,
    2. Turner R,
    3. Douek P,
    4. et al

    . Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992;159:591–99

    PubMedWeb of Science
14. 14.↵
    1. Ito M,
    2. Watanabe H,
    3. Kawai Y,
    4. et al

    . Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. J Neurol Neurosurg Psychiatry 2007;78:722–28

    Abstract/FREE Full Text
15. 15.↵
    1. Schocke MF,
    2. Seppi K,
    3. Esterhammer R,
    4. et al

    . Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 2004;21:1443–51

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Kanazawa M,
    2. Shimohata T,
    3. Terajima K,
    4. et al

    . Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging. J Neurol 2004;251:1121–24

    PubMedWeb of Science
17. 17.↵
    1. Shiga K,
    2. Yamada K,
    3. Yoshikawa K,
    4. et al

    . Local tissue anisotropy decreases in cerebellopetal fibers and pyramidal tract in multiple system atrophy. J Neurol 2005;252:589–96. Epub 2005 Apr 18

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Graham DI,
    2. Lantos PL

    1. Lowe J,
    2. Lennox G,
    3. Leigh PN

    . Disorders of movement and system degeneration. In: Graham DI, Lantos PL eds. Greenfield's Neuropathology. 6th ed. London, UK; Arnold; 1997:297–300
19. 19.↵
    1. Blamire AM,
    2. Rowe JG,
    3. Styles P,
    4. et al

    . Optimising imaging parameters for post mortem MR imaging of the human brain. Acta Radiol 1999;40:593–97

    PubMed
20. 20.↵
    1. Wenning GK,
    2. Tison F,
    3. Elliott L,
    4. et al

    . Olivopontocerebellar pathology in multiple system atrophy. Mov Disord 1996;11:157–62

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Mizutani T

    . Pathological issues of spinocerebellar degeneration. Clin Neurosci (Japanese) 1993;11:618–25
22. 22.↵
    1. Hallgren B,
    2. Sourander P

    . The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41–51

    CrossRefPubMedWeb of Science